Welcome back to the Class Action & MDL Roundup! Our winter edition covers notable class actions from the fourth quarter of 2020.
In this edition, we find a common theme among COVID-19 class actions, the Tampa 2 defends against five, and investors are a little more secure. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
We wrap up the Roundup with a summary of class action settlements finalized in the fourth quarter.
